Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Soho Global Health TbkISX:SOHO +0.42%87 Days Payable is 104.07 as of Jun. 2026, which is 13% above its 10-year median of 92.17. GuruFocus rates ISX:SOHO with a GF Score™ of 87/100 and a GF Value™ of Rp805.04 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 119 Medical Distribution companies, PT Soho Global Health Tbk ranks better than 64.71% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:SOHO vs MCK, COR, CAH: Days Payable Comparison
For the Medical Distribution subindustry, PT Soho Global Health Tbk's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Soho Global Health Tbk Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Soho Global Health Tbk's Days Payable distribution charts can be found below:
* The bar in red indicates where PT Soho Global Health Tbk's Days Payable falls into.
PT Soho Global Health Tbk Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PT Soho Global Health Tbk's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Soho Global Health Tbk (ISX:SOHO) has a Days Payable of 104.07 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Soho Global Health Tbk and its competitors. This is 13% above median its historical median of 92.17. Over the past decade, PT Soho Global Health Tbk's Days Payable has ranged from 88.29 to 102.08. According to the industry distribution chart, PT Soho Global Health Tbk ranks #42 out of 119 companies in the Medical Distribution industry, placing it in the top 35.3%.
Is PT Soho Global Health Tbk's Days Payable too high?
PT Soho Global Health Tbk's current Days Payable of 104.07 is 13% above median its 10-year median of 92.17. Over the past 10 years, this metric has ranged from a low of 88.29 to a high of 102.08. The Medical Distribution industry median Days Payable is 78.20. PT Soho Global Health Tbk's value of 104.07 is 33.1% above this industry median. Based on the distribution chart, PT Soho Global Health Tbk ranks #42 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Soho Global Health Tbk has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Soho Global Health Tbk's Days Payable compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Soho Global Health Tbk ranks #42 out of 119 companies for Days Payable. This puts PT Soho Global Health Tbk in the upper half of its industry. The industry median Days Payable is 78.20. PT Soho Global Health Tbk's value of 104.07 is 33.1% above this benchmark. Historically, PT Soho Global Health Tbk's own Days Payable has ranged from 88.29 to 102.08 over the past decade. While the company's 10-year median is 92.17 vs. the industry median of 78.20, PT Soho Global Health Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 78.20, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Soho Global Health Tbk's current Days Payable of 104.07 is 33.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Soho Global Health Tbk and its competitors. For the Medical Distribution industry, the median Days Payable is 78.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Soho Global Health Tbk's current Days Payable is 104.07, which is 13% above median its own 10-year median of 92.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Soho Global Health Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Soho Global Health Tbk (ISX:SOHO) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp805.04, compared to a current price of Rp1,205.00 — trading 49.7% above its estimated fair value. The current Days Payable is 104.07, which is 13% above median its 10-year median of 92.17 and 33.1% above the Medical Distribution industry median of 78.20. PT Soho Global Health Tbk's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PT Soho Global Health Tbk (ISX:SOHO), the current Days Payable is 104.07 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Soho Global Health Tbk (ISX:SOHO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Soho Global Health Tbk stock appears to be overvalued.
The current stock price of Rp1,205.00 is trading 49.7% above its estimated GF Value™ of Rp805.04.
GuruFocus considers PT Soho Global Health Tbk to be Significantly Overvalued.
Key valuation signals for ISX:SOHO:
Days Payable: 104.07 (13% above median its 10-year median of 92.17)
GF Value™: Rp805.04 vs. price of Rp1,205.00 (49.7% above fair value)
Industry Position: 33.1% above the Medical Distribution median (#42 of 119)
No single metric tells the full story. See the ISX:SOHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products, including herbal cures, proprietary medicines, and health foods, under various brand names such as Curcuma Plus, Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho, and Sohobion. Its segment includes Distribution, Consumer health, Alliance, and others. The company generates maximum revenue from the Distribution segment.
87GF Score
Get the complete analysis for ISX:SOHO
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SOHO has been successfully added to your 
